Charlson and Elixhauser Comorbidity Indices for Prediction of Mortality and Hospital Readmission in Patients With Acute Pulmonary Embolism

• Published in: Clinical and applied thrombosis/hemostasis 2024-01, Vol.30, p.10760296241253844-10760296241253844
• Main Authors: O'Hara, Alexander, Pozin, Jacob, Abourahma, Mohammed, Gigstad, Ryan, Torres, Danny, Knapp, Benji, Kantarcioglu, Bulent, Fareed, Jawed, Darki, Amir
• Format: Article
• Language: English
• Subjects: Acute Disease; Aged; Aged, 80 and over; Comorbidity; Female; Hospital Mortality; Humans; Male; Middle Aged; Original; Patient Readmission - statistics & numerical data; Prognosis; Pulmonary Embolism - mortality; Retrospective Studies
• ISSN: 1076-0296; 1938-2723
• DOI: 10.1177/10760296241253844

Several risk stratification systems aid clinicians in classifying pulmonary embolism (PE) severity and prognosis. We compared 2 clinical PE scoring systems, the PESI and sPESI scores, with 2 comorbidity indices, the Charlson Comorbidity Index (CCI) and the val Walraven Elixhauser Comorbidity Index (ECI), to determine the utility of each in predicting mortality and hospital readmission. Information was collected from 436 patients presenting with PE via retrospective chart review. The PESI, sPESI, CCI, and ECI scores were calculated for each patient. Multivariate analysis was used to determine each system's ability to predict in-hospital mortality, 90-day mortality, overall mortality, and all-cause hospital readmission. The impact of various demographic and clinical characteristics of each patient on these outcomes was also assessed. The PESI score was found to be an independent predictor of in-hospital mortality and 90-day mortality. The PESI score and the CCI were able to independently predict overall mortality. None of the 4 risk scores independently predicted hospital readmission. Other factors including hypoalbuminemia, serum BNP, coagulopathy, anemia, and diabetes were associated with increased mortality and readmission at various endpoints. The PESI score was the best tool for predicting mortality at any endpoint. The CCI may have utility in predicting long-term outcomes. Further work is needed to better determine the roles of the CCI and ECI in predicting patient outcomes in PE. The potential prognostic implications of low serum albumin and anemia at the time of PE also warrant further investigation.